Search

Magdalene K. Sgagias

Examiner (ID: 4537, Phone: (571)272-3305 , Office: P/1632 )

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
637
Issued Applications
229
Pending Applications
42
Abandoned Applications
366

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5709987 [patent_doc_number] => 20060051332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Generation of histocompatible tissues using nuclear transplantation' [patent_app_type] => utility [patent_app_number] => 10/515705 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10737 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051332.pdf [firstpage_image] =>[orig_patent_app_number] => 10515705 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/515705
Generation of histocompatible tissues using nuclear transplantation May 22, 2003 Abandoned
Array ( [id] => 7403420 [patent_doc_number] => 20040023881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections' [patent_app_type] => new [patent_app_number] => 10/439047 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8609 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023881.pdf [firstpage_image] =>[orig_patent_app_number] => 10439047 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/439047
Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections May 15, 2003 Abandoned
Array ( [id] => 7178865 [patent_doc_number] => 20050204407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Methods for identifying and developing compounds that interact with voltage-gated potassium channels of the kv4 family' [patent_app_type] => utility [patent_app_number] => 10/514316 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19707 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20050204407.pdf [firstpage_image] =>[orig_patent_app_number] => 10514316 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/514316
Methods for identifying and developing compounds that interact with voltage-gated potassium channels of the kv4 family May 13, 2003 Abandoned
Array ( [id] => 5732249 [patent_doc_number] => 20060257366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Chimeric glycoproteins and pseudotyped lentiviral vectors' [patent_app_type] => utility [patent_app_number] => 10/512474 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 34825 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257366.pdf [firstpage_image] =>[orig_patent_app_number] => 10512474 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/512474
Chimeric glycoproteins and pseudotyped lentiviral vectors Apr 24, 2003 Issued
Array ( [id] => 6966560 [patent_doc_number] => 20050233457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Recombining viral vectors for the tetracycline-regulated expression of genes' [patent_app_type] => utility [patent_app_number] => 10/511237 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6627 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233457.pdf [firstpage_image] =>[orig_patent_app_number] => 10511237 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/511237
Recombining viral vectors for the tetracycline-regulated expression of genes Apr 7, 2003 Abandoned
Array ( [id] => 7355074 [patent_doc_number] => 20040048821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Enhancement of drug cytotoxicity in tumor cells containing mutant Rb gene' [patent_app_type] => new [patent_app_number] => 10/401116 [patent_app_country] => US [patent_app_date] => 2003-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9473 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048821.pdf [firstpage_image] =>[orig_patent_app_number] => 10401116 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/401116
Enhancement of drug cytotoxicity in tumor cells containing mutant Rb gene Mar 25, 2003 Abandoned
Array ( [id] => 6771432 [patent_doc_number] => 20030217372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Methods of using alpha 1b-adrenergic receptors' [patent_app_type] => new [patent_app_number] => 10/396952 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16071 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20030217372.pdf [firstpage_image] =>[orig_patent_app_number] => 10396952 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/396952
Methods of using alpha 1b-adrenergic receptors Mar 24, 2003 Abandoned
Array ( [id] => 7136298 [patent_doc_number] => 20040044006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Methods of use of quinolone compounds against pneumococcal and haemophilus bacteria' [patent_app_type] => new [patent_app_number] => 10/395461 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14443 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20040044006.pdf [firstpage_image] =>[orig_patent_app_number] => 10395461 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/395461
Methods of use of quinolone compounds against pneumococcal and Haemophilus bacteria Mar 23, 2003 Issued
Array ( [id] => 7233124 [patent_doc_number] => 20050256067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Method of preparing a treatment product, treatment product and a plasmid construct' [patent_app_type] => utility [patent_app_number] => 10/505933 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7266 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256067.pdf [firstpage_image] =>[orig_patent_app_number] => 10505933 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/505933
Method of preparing a treatment product, treatment product and a plasmid construct Feb 26, 2003 Abandoned
Array ( [id] => 53726 [patent_doc_number] => 07772459 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Transgenic production in saliva' [patent_app_type] => utility [patent_app_number] => 10/505191 [patent_app_country] => US [patent_app_date] => 2003-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34543 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772459.pdf [firstpage_image] =>[orig_patent_app_number] => 10505191 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/505191
Transgenic production in saliva Feb 19, 2003 Issued
Array ( [id] => 6796782 [patent_doc_number] => 20030175656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Hydrogel incorporated with bone growth promoting agents for dental and oral surgery' [patent_app_type] => new [patent_app_number] => 10/344942 [patent_app_country] => US [patent_app_date] => 2003-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9882 [patent_no_of_claims] => 112 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175656.pdf [firstpage_image] =>[orig_patent_app_number] => 10344942 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/344942
Hydrogel incorporated with bone growth promoting agents for dental and oral surgery Feb 18, 2003 Abandoned
Array ( [id] => 5726814 [patent_doc_number] => 20060057574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Tissue specific expression' [patent_app_type] => utility [patent_app_number] => 10/504809 [patent_app_country] => US [patent_app_date] => 2003-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8482 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057574.pdf [firstpage_image] =>[orig_patent_app_number] => 10504809 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/504809
Tissue specific expression Feb 18, 2003 Abandoned
Array ( [id] => 6648686 [patent_doc_number] => 20030213003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Transgenically produced non-secreted proteins' [patent_app_type] => new [patent_app_number] => 10/358037 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11093 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20030213003.pdf [firstpage_image] =>[orig_patent_app_number] => 10358037 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/358037
Transgenically produced non-secreted proteins Feb 3, 2003 Abandoned
Array ( [id] => 6769877 [patent_doc_number] => 20030215817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Modulation of gene expression in formation of fatty atherosclerotic lesions' [patent_app_type] => new [patent_app_number] => 10/182230 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 47289 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215817.pdf [firstpage_image] =>[orig_patent_app_number] => 10182230 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/182230
Modulation of gene expression in formation of fatty atherosclerotic lesions Feb 2, 2003 Abandoned
Array ( [id] => 7467842 [patent_doc_number] => 20040053871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Immunization of infants' [patent_app_type] => new [patent_app_number] => 10/351630 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14370 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053871.pdf [firstpage_image] =>[orig_patent_app_number] => 10351630 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/351630
Immunization of infants Jan 23, 2003 Abandoned
Array ( [id] => 7280374 [patent_doc_number] => 20040062751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Methods for inhibiting angiogenesis' [patent_app_type] => new [patent_app_number] => 10/346589 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4934 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20040062751.pdf [firstpage_image] =>[orig_patent_app_number] => 10346589 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/346589
Methods for inhibiting angiogenesis Jan 16, 2003 Abandoned
Array ( [id] => 83305 [patent_doc_number] => 07741112 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Vector mediated organelle transfection' [patent_app_type] => utility [patent_app_number] => 10/498328 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 11196 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741112.pdf [firstpage_image] =>[orig_patent_app_number] => 10498328 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/498328
Vector mediated organelle transfection Dec 11, 2002 Issued
Array ( [id] => 6952206 [patent_doc_number] => 20050227300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/497333 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3557 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227300.pdf [firstpage_image] =>[orig_patent_app_number] => 10497333 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/497333
Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitors Dec 5, 2002 Abandoned
Array ( [id] => 6661228 [patent_doc_number] => 20030135872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Gene targeting methods and vectors' [patent_app_type] => new [patent_app_number] => 10/309757 [patent_app_country] => US [patent_app_date] => 2002-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13347 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 237 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20030135872.pdf [firstpage_image] =>[orig_patent_app_number] => 10309757 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/309757
Gene targeting methods and vectors Dec 2, 2002 Abandoned
Array ( [id] => 7010244 [patent_doc_number] => 20050063960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Dna construct for assessing thymic function activity and therapeutical uses thereof' [patent_app_type] => utility [patent_app_number] => 10/496916 [patent_app_country] => US [patent_app_date] => 2002-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4720 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20050063960.pdf [firstpage_image] =>[orig_patent_app_number] => 10496916 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/496916
Dna construct for assessing thymic function activity and therapeutical uses thereof Nov 28, 2002 Abandoned
Menu